Wyeth Wants Premarin Petitions Excluded From Duramed Antitrust Suit

Wyeth-Ayerst's efforts to influence regulatory decisions about conjugated estrogens via citizens' petitions are an early focus of arguments in Duramed's antitrust suit against the company.